Aim Immunotech Correlations

AIM
 Stock
  

USD 0.57  0.01  1.79%   

The correlation of Aim Immunotech is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aim Immunotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aim Immunotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please continue to Trending Equities.
  
The ability to find closely correlated positions to Aim Immunotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aim Immunotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aim Immunotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aim Immunotech to buy it.

Moving together with Aim Immunotech

+0.65NVONovo Nordisk ASPairCorr
+0.64NONOFNOVO NORDISK ASPairCorr
+0.67CSLLYCsl Ltd ADRPairCorr
+0.86MRNAModernaPairCorr
+0.83BNTXBiontech Se ADRPairCorr
+0.72OSTKOOVERSTOCK COM INCPairCorr
+0.91PFEPfizer IncPairCorr
+0.75KOCoca-ColaPairCorr

Moving against Aim Immunotech

-0.71ADRTAult Disruptive TechPairCorr
-0.69REGNRegeneron PharmaceuticalsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ASHTYASHTF
ASHTYTRTN
ASHTFTRTN
LZRFYMGRC
ASHTYCAR
CARR
  

Aim Immunotech Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Aim Immunotech Stock performing well and Aim Immunotech company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Aim Immunotech's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aim Immunotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Aim Immunotech Corporate Directors

Aim Immunotech corporate directors refer to members of an Aim Immunotech board of directors. The board of directors generally takes responsibility for the Aim Immunotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Aim Immunotech's board members must vote for the resolution. The Aim Immunotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Kean Lee - Non-Executive Independent DirectorProfile
Chin Tan - Executive DirectorProfile
Siew Mak - Executive DirectorProfile
Azizullaili Jalaluddin - Independent Non-Executive DirectorProfile

Invested in Aim Immunotech?

The danger of trading Aim Immunotech is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aim Immunotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aim Immunotech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aim Immunotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for analysis

When running Aim Immunotech price analysis, check to measure Aim Immunotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aim Immunotech is operating at the current time. Most of Aim Immunotech's value examination focuses on studying past and present price action to predict the probability of Aim Immunotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aim Immunotech's price. Additionally, you may evaluate how the addition of Aim Immunotech to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Aim Immunotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aim Immunotech. If investors know Aim Immunotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aim Immunotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aim Immunotech is measured differently than its book value, which is the value of Aim Immunotech that is recorded on the company's balance sheet. Investors also form their own opinion of Aim Immunotech's value that differs from its market value or its book value, called intrinsic value, which is Aim Immunotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aim Immunotech's market value can be influenced by many factors that don't directly affect Aim Immunotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aim Immunotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Aim Immunotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aim Immunotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.